Target intelligence / Profile preview

PRELI domain containing 3B pseudogene 11 (PRELID3BP11)

Target
PRELID3BP11
Molecular classification
Other (Pseudogene)
01

Overview

PRELI domain containing 3B pseudogene 11 (PRELID3BP11) is a processed pseudogene in humans. It shares sequence similarity with the functional PRELI domain containing 3B gene but does not produce a functional protein product and has lost its protein-coding capability. Classified as a pseudogene, it does not have a known biological function and is not recognized as a therapeutic target, receptor, enzyme, or transporter. Key details supporting this classification: - The gene is listed as a pseudogene by multiple authoritative sources, including NCBI, HGNC, GeneCards, and others. - No biological function, disease association, or interaction with drugs has been described. - The locus is a retrocopy (processed pseudogene) of the parental gene PRELID3B and is not functional as a protein-coding gene. - It is not considered a therapeutic target. There are no apparent misspellings or major errors in the naming; however, since it is a pseudogene, it does not meet the criteria typically required for a "target" molecule in drug discovery or therapeutic contexts.

Other names
SLMO2P11SLMO2 pseudogene 11slowmo homolog 2 (Drosophila) pseudogene 11PRELID3BP11

Beyond the preview

Go deeper on PRELI domain containing 3B pseudogene 11 (PRELID3BP11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRELI domain containing 3B pseudogene 11 (PRELID3BP11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call